Anzeige
Mehr »
Donnerstag, 21.05.2026 - Börsentäglich über 12.000 News
Nach dem Tungsten-Schock: Startet hier jetzt die nächste große US-Critical-Minerals-Story?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PZ3E | ISIN: US18507C1036 | Ticker-Symbol:
NASDAQ
21.05.26 | 21:59
11,700 US-Dollar
+4,74 % +0,530
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CLEARPOINT NEURO INC Chart 1 Jahr
5-Tage-Chart
CLEARPOINT NEURO INC 5-Tage-Chart

Aktuelle News zur CLEARPOINT NEURO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22:30ClearPoint Neuro, Inc. - 8-K, Current Report1
MiClearPoint Neuro, Inc. - S-8, Securities to be offered to employees in employee benefit plans2
14.05.Stifel reiterates Clearpoint Neuro stock Buy rating after Q1 beat1
13.05.ClearPoint Neuro Q1 2026 Earnings Call Transcript1
13.05.ClearPoint Neuro, Inc. - 10-Q, Quarterly Report1
13.05.ClearPoint Neuro, Inc. GAAP EPS of -$0.32 misses by $0.05, revenue of $12.13M beats by $0.16M13
CLEARPOINT NEURO Aktie jetzt für 0€ handeln
13.05.ClearPoint Neuro surgical drill receives CE Mark approval2
13.05.ClearPoint Neuro, Inc.: ClearPoint Neuro Reports First Quarter 2026 Results1.531Record Revenue Achieved Including 25% Organic Growth in Devices and 43% Overall Growth SOLANA BEACH, CA / ACCESS Newswire / May 13, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global...
► Artikel lesen
13.05.Chirurgischer Bohrer von ClearPoint Neuro erhält CE-Zulassung für Europa2
13.05.ClearPoint Neuro, Inc. - 8-K, Current Report2
13.05.ClearPoint Neuro, Inc.: ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint256SOLANA BEACH, CA / ACCESS Newswire / May 13, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain...
► Artikel lesen
08.05.Stifel initiates Clearpoint Neuro stock coverage with buy rating1
29.04.ClearPoint Neuro, Inc.: ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026779SOLANA BEACH, CA / ACCESS Newswire / April 29, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the...
► Artikel lesen
22.04.ClearPoint Neuro, Inc.: ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint797SOLANA BEACH, CA / ACCESS Newswire / April 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain...
► Artikel lesen
20.04.ClearPoint Neuro gets Canadian approval for navigation system2
20.04.ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint326Combined clearance of the navigation and drug delivery technologies enables Canadian neurosurgery centers to leverage the Company's flagship image-guidance workflow and advances ClearPoint Neuro's overall...
► Artikel lesen
18.03.ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates3
18.03.ClearPoint Neuro outlines $52M-$56M 2026 revenue target as company advances growth strategy and integrates IRRAS acquisition1
17.03.ClearPoint Neuro: Umsatzwachstum in Q4 2025 treibt Aktie nachbörslich an1
17.03.ClearPoint Neuro, Inc. - 10-K, Annual Report1
Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1